163 related articles for article (PubMed ID: 33777862)
1. miR-16-5p, miR-103-3p, and miR-27b-3p as Early Peripheral Biomarkers of Fetal Growth Restriction.
Tagliaferri S; Cepparulo P; Vinciguerra A; Campanile M; Esposito G; Maruotti GM; Zullo F; Annunziato L; Pignataro G
Front Pediatr; 2021; 9():611112. PubMed ID: 33777862
[TBL] [Abstract][Full Text] [Related]
2. First trimester prediction models for small-for- gestational age and fetal growth restricted fetuses without the presence of preeclampsia.
Hromadnikova I; Kotlabova K; Krofta L
Mol Cell Probes; 2023 Dec; 72():101941. PubMed ID: 37951512
[TBL] [Abstract][Full Text] [Related]
3. First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers.
Hromadnikova I; Kotlabova K; Krofta L
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327520
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction.
Hromadnikova I; Kotlabova K; Krofta L
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203467
[TBL] [Abstract][Full Text] [Related]
5. Sexually dimorphic patterns in maternal circulating microRNAs in pregnancies complicated by fetal growth restriction.
Baker BC; Lui S; Lorne I; Heazell AEP; Forbes K; Jones RL
Biol Sex Differ; 2021 Nov; 12(1):61. PubMed ID: 34789323
[TBL] [Abstract][Full Text] [Related]
6. Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications.
Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L; Sirc J
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717412
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved.
Loscalzo G; Scheel J; Ibañez-Cabellos JS; García-Lopez E; Gupta S; García-Gimenez JL; Mena-Mollá S; Perales-Marín A; Morales-Roselló J
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008715
[TBL] [Abstract][Full Text] [Related]
8. MiRNAs Regulating Oxidative Stress: A Correlation with Doppler Sonography of Uteroplacental Complex and Clinical State Assessments of Newborns in Fetal Growth Restriction.
Gusar V; Ganichkina M; Chagovets V; Kan N; Sukhikh G
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33050114
[TBL] [Abstract][Full Text] [Related]
9. Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications.
Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
Int J Cardiol; 2019 Sep; 291():158-167. PubMed ID: 31151766
[TBL] [Abstract][Full Text] [Related]
10. First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers.
Hromadnikova I; Kotlabova K; Krofta L
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409311
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-148b-3p and MicroRNA-25-3p Are Overexpressed in Fetuses with Late-Onset Fetal Growth Restriction.
Morales-Roselló J; García-Giménez JL; Martinez Priego L; González-Rodríguez D; Mena-Mollá S; Maquieira Catalá A; Loscalzo G; Buongiorno S; Jakaite V; Cañada Martínez AJ; Perales Marín A
Fetal Diagn Ther; 2020; 47(9):665-674. PubMed ID: 32585676
[TBL] [Abstract][Full Text] [Related]
12. Circulating MicroRNAs in maternal blood as potential biomarkers for fetal hypoxia in-utero.
Whitehead CL; Teh WT; Walker SP; Leung C; Larmour L; Tong S
PLoS One; 2013; 8(11):e78487. PubMed ID: 24282500
[TBL] [Abstract][Full Text] [Related]
13. MiR-590-3p and its targets VEGF, PIGF, and MMP9 in early, middle, and late pregnancy: their longitudinal changes and correlations with risk of fetal growth restriction.
Pei J; Li Y; Min Z; Dong Q; Ruan J; Wu J; Hua X
Ir J Med Sci; 2022 Jun; 191(3):1251-1257. PubMed ID: 34159524
[TBL] [Abstract][Full Text] [Related]
14. Second trimester extracellular microRNAs in maternal blood and fetal growth: An exploratory study.
Rodosthenous RS; Burris HH; Sanders AP; Just AC; Dereix AE; Svensson K; Solano M; Téllez-Rojo MM; Wright RO; Baccarelli AA
Epigenetics; 2017 Sep; 12(9):804-810. PubMed ID: 28758828
[TBL] [Abstract][Full Text] [Related]
15. Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction.
Hromadnikova I; Kotlabova K; Ivankova K; Vedmetskaya Y; Krofta L
Int J Cardiol; 2017 Dec; 249():402-409. PubMed ID: 29121743
[TBL] [Abstract][Full Text] [Related]
16. Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy.
Higashijima A; Miura K; Mishima H; Kinoshita A; Jo O; Abe S; Hasegawa Y; Miura S; Yamasaki K; Yoshida A; Yoshiura K; Masuzaki H
Prenat Diagn; 2013 Mar; 33(3):214-22. PubMed ID: 23354729
[TBL] [Abstract][Full Text] [Related]
17. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood.
Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
Thromb Res; 2016 Jan; 137():126-140. PubMed ID: 26632513
[TBL] [Abstract][Full Text] [Related]
18. The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs.
Hromadnikova I; Dvorakova L; Kotlabova K; Krofta L
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216670
[TBL] [Abstract][Full Text] [Related]
19. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Potential of Exosomal HypoxamiRs in the Context of Hypoxia-Sumoylation-HypoxamiRs in Early Onset Preeclampsia at the Preclinical Stage.
Gusar V; Timofeeva A; Chagovets V; Kan N; Vysokikh M; Marey M; Karapetyan A; Baev O; Sukhikh G
Life (Basel); 2022 Jan; 12(1):. PubMed ID: 35054494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
